Determinants Present in the Receptor Carboxy Tail Are Responsible for Differences in Subtype-Specific Coupling of Beta-Adrenergic Receptors to Phosphoinositide 3-Kinase

Overview

Journal Int J Cell Biol

Publisher Wiley

Specialty Cell Biology

Date 2010 Feb 5

PMID 20130777

Authors

Julie Simard

Matthieu Boucher

Rachel Masse

Terence E Hebert

Guy Rousseau

Affiliations

Soon will be listed here.

Abstract

An agonist-occupied beta(2)-adrenergic receptor (beta(2)-AR) recruits G protein receptor kinase-2 (GRK2) which is recruited to the membrane. Thus, the physical proximity of activated beta(2)-AR and PI-3K allows the activation of the latter. In contrast, it has been observed that the beta(1)-AR is unable to activate the PI-3K/Akt pathway. We hypothesized that the difference might be due to molecular determinants present in the carboxy termini of the two beta-AR subtypes. Using transiently transfected HEK 293 cells expressing either beta(1)- or beta(2)-AR, we also observed that in presence of an agonist, beta(2)-AR, but not beta(1)-AR, is able to activate the PI-3K/Akt pathway. Switching the seventh transmembrane domain and the carboxy tail between the two receptors reverses this phenotype; that is, beta(1) x beta(2)-AR can activate the PI-3K/Akt pathway whereas beta(2) x beta(1)-AR cannot. Pretreatment with pertussis toxin abolished the activation of PI-3K by beta(2)- or beta(1) x beta(2)-AR stimulation. Ligand-mediated internalization of the beta(2)-AR induced by a 15-minute stimulation with agonist was abolished in the presence of a dominant negative of PI-3K or following pertussis toxin pretreatment. These results indicate that the subtype-specific differences in the coupling to PI-3K/Akt pathway are due to molecular determinants present in the carboxy tail of the receptor and further that beta(2)-AR activates PI-3K via a pertussis toxin-sensitive mechanism.

References

Boucher M, Pesant S, Falcao S, de Montigny C, Schampaert E, Cardinal R . Post-ischemic cardioprotection by A2A adenosine receptors: dependent of phosphatidylinositol 3-kinase pathway. J Cardiovasc Pharmacol. 2004; 43(3):416-22. DOI: 10.1097/00005344-200403000-00013. View

Prossnitz E . Novel roles for arrestins in the post-endocytic trafficking of G protein-coupled receptors. Life Sci. 2004; 75(8):893-9. DOI: 10.1016/j.lfs.2004.04.003. View

Shiina T, Kawasaki A, Nagao T, Kurose H . Interaction with beta-arrestin determines the difference in internalization behavor between beta1- and beta2-adrenergic receptors. J Biol Chem. 2000; 275(37):29082-90. DOI: 10.1074/jbc.M909757199. View

Chesley A, Lundberg M, Asai T, Xiao R, Ohtani S, Lakatta E . The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3'-kinase. Circ Res. 2000; 87(12):1172-9. DOI: 10.1161/01.res.87.12.1172. View

Marchese A, Chen C, Kim Y, Benovic J . The ins and outs of G protein-coupled receptor trafficking. Trends Biochem Sci. 2003; 28(7):369-76. DOI: 10.1016/S0968-0004(03)00134-8. View

Zhu W, Wang S, Chakir K, Yang D, Zhang T, Brown J . Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. J Clin Invest. 2003; 111(5):617-25. PMC: 151893. DOI: 10.1172/JCI16326. View

Barak L, Wilbanks A, Caron M . Constitutive desensitization: a new paradigm for g protein-coupled receptor regulation. Assay Drug Dev Technol. 2004; 1(2):339-46. DOI: 10.1089/15406580360545152. View

Gaidarov I, Krupnick J, Falck J, Benovic J, Keen J . Arrestin function in G protein-coupled receptor endocytosis requires phosphoinositide binding. EMBO J. 1999; 18(4):871-81. PMC: 1171180. DOI: 10.1093/emboj/18.4.871. View

Boucher M, Nim S, de Montigny C, Rousseau G . Alterations of beta-adrenoceptor responsiveness in postischemic myocardium after 72 h of reperfusion. Eur J Pharmacol. 2004; 495(2-3):185-91. DOI: 10.1016/j.ejphar.2004.05.040. View

10.

Naga Prasad S, Laporte S, Chamberlain D, Caron M, Barak L, Rockman H . Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta-arrestin complex. J Cell Biol. 2002; 158(3):563-75. PMC: 2173831. DOI: 10.1083/jcb.200202113. View

11.

Suzuki T, Nguyen C, Nantel F, Bonin H, Valiquette M, Frielle T . Distinct regulation of beta 1- and beta 2-adrenergic receptors in Chinese hamster fibroblasts. Mol Pharmacol. 1992; 41(3):542-8. View

12.

Kuschel M, Zhou Y, Cheng H, Zhang S, Chen Y, Lakatta E . G(i) protein-mediated functional compartmentalization of cardiac beta(2)-adrenergic signaling. J Biol Chem. 1999; 274(31):22048-52. DOI: 10.1074/jbc.274.31.22048. View

13.

Rousseau G, Nantel F, Bouvier M . Distinct receptor domains determine subtype-specific coupling and desensitization phenotypes for human beta1- and beta2-adrenergic receptors. Mol Pharmacol. 1996; 49(4):752-60. View

14.

Kohout T, Lin F, Perry S, Conner D, Lefkowitz R . beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc Natl Acad Sci U S A. 2001; 98(4):1601-6. PMC: 29303. DOI: 10.1073/pnas.98.4.1601. View

15.

Martin N, Whalen E, Zamah M, Pierce K, Lefkowitz R . PKA-mediated phosphorylation of the beta1-adrenergic receptor promotes Gs/Gi switching. Cell Signal. 2004; 16(12):1397-403. DOI: 10.1016/j.cellsig.2004.05.002. View

16.

Naga Prasad S, Barak L, Rapacciuolo A, Caron M, Rockman H . Agonist-dependent recruitment of phosphoinositide 3-kinase to the membrane by beta-adrenergic receptor kinase 1. A role in receptor sequestration. J Biol Chem. 2001; 276(22):18953-9. DOI: 10.1074/jbc.M102376200. View

17.

Xiao R, Zhu W, Zheng M, Chakir K, Bond R, Lakatta E . Subtype-specific beta-adrenoceptor signaling pathways in the heart and their potential clinical implications. Trends Pharmacol Sci. 2004; 25(7):358-65. DOI: 10.1016/j.tips.2004.05.007. View

18.

Jo S, Leblais V, Wang P, Crow M, Xiao R . Phosphatidylinositol 3-kinase functionally compartmentalizes the concurrent G(s) signaling during beta2-adrenergic stimulation. Circ Res. 2002; 91(1):46-53. DOI: 10.1161/01.res.0000024115.67561.54. View